FDA Approves Zurzuvae, First Pill For Postpartum Depression, What You Need To Know
Zurzuvae, the first-ever oral medication for postpartum depression, has received approval from the U.S. Food and Drug Administration (FDA). Postpartum depression affects approximately one in seven women during pregnancy or after giving birth. (Photo: Getty) getty Exciting news for those dealing with postpartum depression! On August 4, the U.S. Food and Drug Administration (FDA) announced …